CR-001 IND cleared by U.S. FDA; Phase 1/2 ASCEND global clinical trial to evaluate CR-001 in first-line and previously ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech or the Company, 6990.HK) announced that its Investigational ...

Crescent Biopharma (CBIO) announced regulatory clearances of Investigational New Drug applications for CR-001, a PD-1 x VEGF bispecific antibody, ...

Co. Ltd. has synthesized integrin β2 regulators reported to be useful for the treatment of alopecia areata, gouty arthritis, autoimmune hepatitis, inflammatory bowel disease, peritonitis, rheumatoid ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

iPadOS 26.2 launched last week, and now Apple has shipped the first iPadOS 26.3 beta to developers. Here’s what to expect. iPadOS 26.3 beta 1 is here, and it’s likely Apple’s last software release ...

With Apple about to release iOS 26.2 to iPhone users, the company should start beta testing iOS 26.3 before the year ends. While it's unclear what Apple might be planning for this update, besides an ...

Apple has officially released iOS 26.2 for iPhone. The latest version includes Liquid Glass design tweaks, new customization options for CarPlay, and much more. Today’s release is available for all ...

We read with interest the article by Santacroce about personalised medicine in eosinophilic oesophagitis (EoE) and the ...